Cochlear, based in Sydney, has recently finished recruiting participants for its global pivotal trial assessing fully implantable hearing technology. Patients enrolled in Cochlear’s research programs have collectively logged over 1 million hours with the device. This milestone highlights the extensive research endeavors dedicated to fully implantable hearing technology, emphasizing Cochlear's unwavering dedication to advancing this innovative field. The program signals a significant step forward in enhancing hearing capabilities.
